GBI METRIX is a researcher intelligence platform that brings together large-scale public academic and industry data to create rich, dynamic profiles of researchers and HCPs. Powered by proprietary tagging, evaluation models, and continuous tracking, it supports HCP360 profiling and KOL mapping, helping pharmaceutical companies identify, evaluate, and engage key opinion leaders throughout the product life cycle.
Identifying High-Value HCPs
With millions of researchers and HCPs to evaluate, companies often struggle to identify those with the greatest scientific influence, strategic relevance, and collaboration potential, making KOL engagement and resource allocation less effective.
Building Meaningful HCP Engagement
Limited visibility into HCP research interests, academic activities, and areas of expertise makes it difficult for commercial and medical teams to deliver relevant scientific engagement and build lasting relationships.
Keeping Track of KOL Activity
Tracking changes in research output, academic activities, clinical trial participation, and professional influence is challenging. Without timely visibility, valuable collaboration and engagement opportunities can easily be overlooked.
GBI METRIX brings together publicly available academic, clinical, and professional data to create comprehensive researcher profiles. Powered by proprietary algorithms, the platform combines HCP tagging, evaluation, profiling, tracking, and relationship mapping with AI-driven analytics, enabling pharmaceutical companies to identify, engage, and monitor HCPs and KOLs more effectively.
Access profiles for more than 5 million researchers, combining publications, clinical trials, grants, professional society memberships, academic appointments, conference roles, and collaboration networks into a single, searchable profile.
Powered by a proprietary HCP tagging and evaluation framework developed through decades of industry experience and collaboration with leading pharmaceutical companies, GBI METRIX helps identify, prioritize, and track high-value researchers and KOLs.
Leverage AI-driven analytics to uncover relationship networks, identify emerging opinion leaders, and generate actionable insights that support HCP engagement and commercial strategy.
GBI Health unites global pharmaceutical data, AI capabilities and industry expertise to deliver future-ready solutions across the entire product lifecycle.
Contact Us
